May 17, 2021 / 08:30PM GMT
Operator
Welcome to Amarin Corporation's American College of Cardiology's 70th Annual Scientific session discussion where select scientific publications presented over the weekend will be discussed. This conference call is being recorded today, May 17, 2021. I would now turn the conference call over to Alina Kolomeyer, Director of Communications at Amarin.
Alina Kolomeyer - Amarin Corporation plc - Director of Communications
Welcome to today's discussion with several distinguished invited guests to explore with our investment community the several important new data sets and analyses related to VASCEPA and REDUCE-IT presented to the medical community at the American College of Cardiology's 70th Annual Scientific session. We are honored today to be able to bring to you for your consideration, the opinions of an esteemed group of clinicians and scientists. Opinions expressed by the clinicians and scientists on this webcast are theirs alone. They have neither been scripted nor previewed by Amarin. While Amarin values their perspective, we may not necessarily agree with their
Amarin Corporation PLC Acc.21 From Bench to Bedside and Beyond - Corporate Call Transcript
May 18, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers